Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

McMaster University

$135,000.00

Chemical-genomics approach to identify new targets for antibiotics in Salmonella Typhimurium

EF 2016-17

Résumé
Antibiotic drug resistance has reached crisis levels, in part because modern drug discovery attempts have failed to identify new antibiotics. The solution to this crisis requires a paradigm shift from traditional drug discovery platforms. Most antibiotics target a small number of bacterial processes, including ribosome function, cell wall synthesis, and DNA topology. Many small molecule screening campaigns employ reductionist approaches focused on a small number of validated target proteins. Traditionally, genes that are required for bacterial growth in standard laboratory conditions were pursued as drug targets. However, in the course of an infection bacteria encounter many harsh environments that are a component of the natural host defence against microbes (innate immunity). Bacteria such as Salmonella evade the innate immune response and in some cases use innate immunity as a signal to promote pathogenesis. I propose that the genes and bacterial processes involved in subverting the immune response are suitable candidates for development of fresh antibiotics. In the work proposed here I will use high-throughput genetic arrays to find genes and pathways in Salmonella that allow this pathogen to subvert the host immune response. I will use this knowledge to develop a screen of 50,000 natural products, pre-approved drugs, and chemically diverse small molecules to identify new leads for the development of antibiotics. This pilot screen can be scaled-up to include ~500,000 compounds. This research will help us begin to unravel the complex genetic interactions that govern bacterial pathogenesis and could identify new leads for antibiotics targeting Gram-negative bacteria.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
361690
Name
Ellis Michael J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Chemical-genomics approach to identify new targets for antibiotics in Salmonella Typhimurium
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antibiotic; Bacteria; Chemical Biology; Chemical Genetics; Enteric Pathogen; Gram-Negative Bacteria; Innate Immunity; Salmonella Typhimurium; Small Molecule Screening
Abstract
Antibiotic drug resistance has reached crisis levels, in part because modern drug discovery attempts have failed to identify new antibiotics. The solution to this crisis requires a paradigm shift from traditional drug discovery platforms. Most antibiotics target a small number of bacterial processes, including ribosome function, cell wall synthesis, and DNA topology. Many small molecule screening campaigns employ reductionist approaches focused on a small number of validated target proteins. Traditionally, genes that are required for bacterial growth in standard laboratory conditions were pursued as drug targets. However, in the course of an infection bacteria encounter many harsh environments that are a component of the natural host defence against microbes (innate immunity). Bacteria such as Salmonella evade the innate immune response and in some cases use innate immunity as a signal to promote pathogenesis. I propose that the genes and bacterial processes involved in subverting the immune response are suitable candidates for development of fresh antibiotics. In the work proposed here I will use high-throughput genetic arrays to find genes and pathways in Salmonella that allow this pathogen to subvert the host immune response. I will use this knowledge to develop a screen of 50,000 natural products, pre-approved drugs, and chemically diverse small molecules to identify new leads for the development of antibiotics. This pilot screen can be scaled-up to include ~500,000 compounds. This research will help us begin to unravel the complex genetic interactions that govern bacterial pathogenesis and could identify new leads for antibiotics targeting Gram-negative bacteria.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ellis, Michael J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~